Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF-κB signalling pathway.

Journal of Cellular and Molecular Medicine
Jiansen LuXiao Yu

Abstract

Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and synovitis during OA. PAB, a diterpene acid, specifically inhibited NF-κB signalling and reduced the production of pro-inflammatory cytokines, which further decreased M1 polarization and vessel formation. We further provide in vivo and in vitro evidences that PAB suppressed NF-κB signalling by stabilizing PPARγ. Using PPARγ antagonist could abolish anti-inflammatory effect of PAB and rescue the activation of NF-κB signalling during OA. Our findings identify a previously unrecognized role of PAB in the regulation of OA and provide mechanisms by which PAB regulates NF-κB signalling through PPARγ, which further suggest targeting synovial inflammation or inhibiting vessel formation at early stage could be an effective preventive strategy for OA.

References

Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mei-Hong LiJian Ding
Feb 26, 2005·Annals of the Rheumatic Diseases·M J BenitoB Bresnihan
Aug 14, 2008·Current Opinion in Rheumatology·Carla R ScanzelloMary K Crow
Mar 23, 2010·Cell·Osamu Takeuchi, Shizuo Akira
Apr 16, 2010·Annals of the New York Academy of Sciences·J P Dyke, R K Aaron
Sep 21, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Laurence PesesseYves Henrotin
Jun 21, 2011·Lancet·Johannes W J BijlsmaFloris P J G Lafeber
Jan 24, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tan LiShu-Fang Bai
May 4, 2013·Therapeutic Advances in Musculoskeletal Disease·Jeremy Sokolove, Christin M Lepus
Feb 4, 2014·Therapeutic Advances in Musculoskeletal Disease·Yves HenrotinCecile Lambert
Dec 10, 2014·Annals of the Rheumatic Diseases·I AtukoralaD J Hunter
Mar 10, 2015·Lancet·S Glyn-JonesA J Carr
Jun 30, 2015·Nature Medicine·Haitao GuoJenny P-Y Ting
Aug 20, 2016·Nature Reviews. Rheumatology·William H RobinsonJeremy Sokolove
Jun 24, 2017·Journal of Cellular and Molecular Medicine·Zuqiang WangXiaolan Du
Jan 11, 2018·Journal of Cellular Physiology·Abbas Shapouri-MoghaddamAmirhossein Sahebkar
Jan 13, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Jiansen LuXiaochun Bai
Jul 12, 2018·Annals of the Rheumatic Diseases·Haiyan ZhangXiaochun Bai
Jul 13, 2018·International Journal of Molecular Sciences·Iona J MacDonaldChih-Hsin Tang
Mar 31, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Jan KorbeckiMieczysław Dutka
Apr 30, 2019·Lancet·David J Hunter, Sita Bierma-Zeinstra
Jun 27, 2019·Annals of the Rheumatic Diseases·Xiaobo ZhuWangsen Cao
Sep 11, 2019·The Journal of Clinical Investigation·Peng TanRong-Fu Wang
Nov 16, 2019·Lancet·Graeme Jones, Tania Winzenberg
Jan 7, 2020·Theranostics·Yi PengJanet L Crane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here